Skip to content
lifestyle.hubspotes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SpyGlass Pharma, Inc.
SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
August 6, 2026
SpyGlass Pharma Appoints Shannon Treviño as General Counsel
June 15, 2026
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System
March 9, 2026
SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit
March 4, 2026
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
February 12, 2026
SpyGlass Pharma Announces Pricing of Initial Public Offering
February 11, 2026